Member of: The Gail Sonenshein Lab
Inflammatory breast cancer is a rare but highly aggressive form of breast cancer. It is characterized by rapid onset and clinical features which are often misdiagnosed as acute mastitis or breast abscess, leading to a delay in proper treatment. Surgery, radiation and chemotherapy have significantly improved patient survival but still, in most cases, the outcome remains poor. My work in the lab focuses on defining the signaling pathways characteristic to inflammatory breast cancer and examining the potential use of Epigallocatechin-3-Gallate (EGCG), a green tea polyphenol with anti-oxidant and anti-cancer qualities, in the treatment of this aggressive disease.
BA, MA, Biology, Clark University, Worcester, MA
PhD, Pathology, Boston University, Boston, MA